R357P (p.Arg357Pro) variant of CYP21A2 (Steroid 21-hydroxylase)
R357P (p.Arg357Pro) in CYP21A2 (Steroid 21-hydroxylase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of not provided; 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.68 / 1. The record also includes population frequency data and published literature.
R357P (p.Arg357Pro) variant details
- p.Arg357Pro
- rs574370139
- 1000Genomes rs574370139
- ExAC rs574370139
- gnomAD rs574370139
- Conflicting interpretations
- not provided; 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
- Missense
- Variant Prioritization Score for Impact Estimate 0.678
- CADD 27.00
- PolyPhen-2 0.99
- SIFT 0.00
- ClinVar: Conflicting classifications of pathogenicity (not provided; 21-Hydroxylase-Deficient Congenital Adrenal Hyperp)
- EBI: Pathogenic (in AH3)
- UniProt: Pathogenic (in AH3)
- Most common in the Non-Finnish European population (allele frequency 3.6e-06)
- Cited in: A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction. (PMID 9187661)
- Cited in: 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia. (PMID 20301350)